Skip to content
STOCK EXCHANGES
AMEX
NASDAQ
NYSE
PRODUCTS
Business Model Canvas
BCG Matrix
DCF Analysis
SWOT Analysis
Porter's Five Forces Analysis
PESTLE Analysis
Marketing Mix Analysis
ANSOFF Matrix
VRIO Analysis
BLOGS
History
Financial Health
Investor Profile
Vision
Search
Cart
0
/
$0.00
EN
EN
ES
PT
FR
AR
DE
VRIO Analysis
Alphabetically, A-Z
Sort
Sort by:
Featured
Best selling
Alphabetically, A-Z
Alphabetically, Z-A
Price, low to high
Price, high to low
Date, old to new
Date, new to old
Load Previous
ACM Research, Inc. (ACMR): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Acme United Corporation (ACU): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
ACNB Corporation (ACNB): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Acorda Therapeutics, Inc. (ACOR): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
ACRES Commercial Realty Corp. (ACR): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Acropolis Infrastructure Acquisition Corp. (ACRO): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Actinium Pharmaceuticals, Inc. (ATNM): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Activision Blizzard, Inc. (ATVI): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Acuity Brands, Inc. (AYI): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
AcuityAds Holdings Inc. (ATY): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Acumen Pharmaceuticals, Inc. (ABOS): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Acurx Pharmaceuticals, Inc. (ACXP): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Acushnet Holdings Corp. (GOLF): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Acutus Medical, Inc. (AFIB): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
ACV Auctions Inc. (ACVA): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Adagene Inc. (ADAG): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Adamis Pharmaceuticals Corporation (ADMP): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Adams Resources & Energy, Inc. (AE): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
AdaptHealth Corp. (AHCO): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Adaptimmune Therapeutics plc (ADAP): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Adaptive Biotechnologies Corporation (ADPT): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Adara Acquisition Corp. (ADRA): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
ADC Therapeutics SA (ADCT): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Addex Therapeutics Ltd (ADXN): VRIO Analysis [10-2024 Updated]
1 review
$7.00
$12.00
Load More
![ACM Research, Inc. (ACMR): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acmr-vrio-analysis.png?v=1730200784&width=1)
![ACM Research, Inc. (ACMR): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acmr-vrio-analysis.png?v=1730200784&width=600)
![Acme United Corporation (ACU): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acu-vrio-analysis.png?v=1730200801&width=1)
![Acme United Corporation (ACU): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acu-vrio-analysis.png?v=1730200801&width=600)
![ACNB Corporation (ACNB): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acnb-vrio-analysis.png?v=1730200801&width=1)
![ACNB Corporation (ACNB): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acnb-vrio-analysis.png?v=1730200801&width=600)
![Acorda Therapeutics, Inc. (ACOR): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acor-vrio-analysis.png?v=1730200784&width=1)
![Acorda Therapeutics, Inc. (ACOR): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acor-vrio-analysis.png?v=1730200784&width=600)
![ACRES Commercial Realty Corp. (ACR): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acr-vrio-analysis.png?v=1730200802&width=1)
![ACRES Commercial Realty Corp. (ACR): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acr-vrio-analysis.png?v=1730200802&width=600)
![Acropolis Infrastructure Acquisition Corp. (ACRO): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acro-vrio-analysis.png?v=1730200802&width=1)
![Acropolis Infrastructure Acquisition Corp. (ACRO): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acro-vrio-analysis.png?v=1730200802&width=600)
![Actinium Pharmaceuticals, Inc. (ATNM): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/atnm-vrio-analysis.png?v=1730200855&width=1)
![Actinium Pharmaceuticals, Inc. (ATNM): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/atnm-vrio-analysis.png?v=1730200855&width=600)
![Activision Blizzard, Inc. (ATVI): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/atvi-vrio-analysis.png?v=1730200855&width=1)
![Activision Blizzard, Inc. (ATVI): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/atvi-vrio-analysis.png?v=1730200855&width=600)
![Acuity Brands, Inc. (AYI): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/ayi-vrio-analysis.png?v=1730200868&width=1)
![Acuity Brands, Inc. (AYI): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/ayi-vrio-analysis.png?v=1730200868&width=600)
![AcuityAds Holdings Inc. (ATY): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/aty-vrio-analysis.png?v=1730200856&width=1)
![AcuityAds Holdings Inc. (ATY): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/aty-vrio-analysis.png?v=1730200856&width=600)
![Acumen Pharmaceuticals, Inc. (ABOS): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/abos-vrio-analysis.png?v=1730200787&width=1)
![Acumen Pharmaceuticals, Inc. (ABOS): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/abos-vrio-analysis.png?v=1730200787&width=600)
![Acurx Pharmaceuticals, Inc. (ACXP): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acxp-vrio-analysis.png?v=1730200784&width=1)
![Acurx Pharmaceuticals, Inc. (ACXP): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acxp-vrio-analysis.png?v=1730200784&width=600)
![Acushnet Holdings Corp. (GOLF): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/golf-vrio-analysis.png?v=1730201138&width=1)
![Acushnet Holdings Corp. (GOLF): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/golf-vrio-analysis.png?v=1730201138&width=600)
![Acutus Medical, Inc. (AFIB): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/afib-vrio-analysis.png?v=1730200798&width=1)
![Acutus Medical, Inc. (AFIB): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/afib-vrio-analysis.png?v=1730200798&width=600)
![ACV Auctions Inc. (ACVA): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acva-vrio-analysis.png?v=1730200802&width=1)
![ACV Auctions Inc. (ACVA): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/acva-vrio-analysis.png?v=1730200802&width=600)
![Adagene Inc. (ADAG): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/adag-vrio-analysis.png?v=1730200803&width=1)
![Adagene Inc. (ADAG): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/adag-vrio-analysis.png?v=1730200803&width=600)
![Adamis Pharmaceuticals Corporation (ADMP): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/admp-vrio-analysis.png?v=1730200802&width=1)
![Adamis Pharmaceuticals Corporation (ADMP): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/admp-vrio-analysis.png?v=1730200802&width=600)
![Adams Resources & Energy, Inc. (AE): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/ae-vrio-analysis.png?v=1730200784&width=1)
![Adams Resources & Energy, Inc. (AE): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/ae-vrio-analysis.png?v=1730200784&width=600)
![AdaptHealth Corp. (AHCO): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/ahco-vrio-analysis.png?v=1730200803&width=1)
![AdaptHealth Corp. (AHCO): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/ahco-vrio-analysis.png?v=1730200803&width=600)
![Adaptimmune Therapeutics plc (ADAP): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/adap-vrio-analysis.png?v=1730200787&width=1)
![Adaptimmune Therapeutics plc (ADAP): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/adap-vrio-analysis.png?v=1730200787&width=600)
![Adaptive Biotechnologies Corporation (ADPT): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/adpt-vrio-analysis.png?v=1730200804&width=1)
![Adaptive Biotechnologies Corporation (ADPT): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/adpt-vrio-analysis.png?v=1730200804&width=600)
![Adara Acquisition Corp. (ADRA): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/adra-vrio-analysis.png?v=1730200803&width=1)
![Adara Acquisition Corp. (ADRA): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/adra-vrio-analysis.png?v=1730200803&width=600)
![ADC Therapeutics SA (ADCT): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/adct-vrio-analysis.png?v=1730200784&width=1)
![ADC Therapeutics SA (ADCT): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/adct-vrio-analysis.png?v=1730200784&width=600)
![Addex Therapeutics Ltd (ADXN): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/adxn-vrio-analysis.png?v=1730200784&width=1)
![Addex Therapeutics Ltd (ADXN): VRIO Analysis [10-2024 Updated]](http://dcf.fm/cdn/shop/files/adxn-vrio-analysis.png?v=1730200784&width=600)